Physician profile
Eric Stewart
NPI 1205569563
$1,542.59
in general payments reported to CMS, 2019-2025
13 companies · $637 in 2025
The $637 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $105 · 2023: $439 · 2024: $361 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $576.59 | 2023-2025 | Total30, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $228.79 | 2023-2025 | Infuse Multifocal, Miebo, Infuse |
| Tarsus Pharmaceuticals, INC. | $224.82 | 2024-2025 | Xdemvy |
| Coopervision INC. | $142.37 | 2025 | Misight Contact Lens, Clariti Contact Lens |
| Dompe US, INC. | $110.90 | 2023 | Oxervate |
| Glaukos Corporation | $71.62 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $64.26 | 2022-2023 | Eylea |
| Sun Pharmaceutical Industries INC. | $33.08 | 2024-2025 | |
| Harrow Eye, LLC | $22.93 | 2025 | Vevye |
| Notal Vision, INC. | $21.23 | 2025 | Foresee Home |
| Alimera Sciences, INC. | $18.97 | 2023 | Iluvien |
| Abbvie INC. | $13.52 | 2024 | |
| Oyster Point Pharma, INC. | $13.51 | 2025 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.